PMID- 23631297
OWN - NLM
STAT- MEDLINE
DCOM- 20130822
LR  - 20211203
IS  - 0385-2385 (Print)
IS  - 0385-2385 (Linking)
VI  - 55
IP  - 2
DP  - 2013
TI  - [The new immunosuppressive drugs for renal transplantation: inhibitors of the 
      mammalian target of rapamycin (mTOR) and anti-thymocyte globulin 
      (Thymoglobulin)].
PG  - 112-8
FAU - Nakagawa, Yuki
AU  - Nakagawa Y
FAU - Ikeda, Masahiro
AU  - Ikeda M
FAU - Tasaki, Masayuki
AU  - Tasaki M
FAU - Saito, Kazuhide
AU  - Saito K
FAU - Takahashi, Kota
AU  - Takahashi K
LA  - jpn
PT  - Journal Article
PT  - Review
PL  - Japan
TA  - Nihon Jinzo Gakkai Shi
JT  - Nihon Jinzo Gakkai shi
JID - 7505731
RN  - 0 (Antilymphocyte Serum)
RN  - 0 (Immunosuppressive Agents)
RN  - EC 2.7.11.1 (TOR Serine-Threonine Kinases)
SB  - IM
MH  - Animals
MH  - Antilymphocyte Serum/*therapeutic use
MH  - Humans
MH  - Immunosuppressive Agents/chemistry/*therapeutic use
MH  - Kidney Transplantation/*immunology
MH  - Signal Transduction/physiology
MH  - T-Lymphocytes/drug effects/metabolism
MH  - TOR Serine-Threonine Kinases/*antagonists & inhibitors
EDAT- 2013/05/02 06:00
MHDA- 2013/08/24 06:00
CRDT- 2013/05/02 06:00
PHST- 2013/05/02 06:00 [entrez]
PHST- 2013/05/02 06:00 [pubmed]
PHST- 2013/08/24 06:00 [medline]
PST - ppublish
SO  - Nihon Jinzo Gakkai Shi. 2013;55(2):112-8.